Try our Advanced Search for more refined results
December 01, 2013
Idenix Pharmaceuticals, Inc. et al v. Gilead Sciences, Inc.
Case Number:
1:13-cv-13052
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 02, 2013
Idenix Suits Target Gilead Hep C Drug Nearing Approval
Idenix Pharmaceuticals Inc. told two federal courts Sunday that Gilead Sciences Inc. is on course to infringe its intellectual property if the U.S. Food and Drug Administration approves Gilead's new drug application for a Hepatitis C treatment as expected this month.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login